1. Home
  2. LGND vs EBC Comparison

LGND vs EBC Comparison

Compare LGND & EBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • EBC
  • Stock Information
  • Founded
  • LGND 1987
  • EBC 1818
  • Country
  • LGND United States
  • EBC United States
  • Employees
  • LGND 68
  • EBC N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • EBC Accident &Health Insurance
  • Sector
  • LGND Health Care
  • EBC Finance
  • Exchange
  • LGND Nasdaq
  • EBC Nasdaq
  • Market Cap
  • LGND 3.2B
  • EBC 3.6B
  • IPO Year
  • LGND 1992
  • EBC 2020
  • Fundamental
  • Price
  • LGND $191.31
  • EBC $17.53
  • Analyst Decision
  • LGND Strong Buy
  • EBC Strong Buy
  • Analyst Count
  • LGND 8
  • EBC 2
  • Target Price
  • LGND $144.71
  • EBC $21.50
  • AVG Volume (30 Days)
  • LGND 139.7K
  • EBC 4.5M
  • Earning Date
  • LGND 08-05-2025
  • EBC 10-23-2025
  • Dividend Yield
  • LGND N/A
  • EBC 2.97%
  • EPS Growth
  • LGND N/A
  • EBC N/A
  • EPS
  • LGND N/A
  • EBC 0.24
  • Revenue
  • LGND $181,488,000.00
  • EBC $627,834,000.00
  • Revenue This Year
  • LGND $18.41
  • EBC $25.13
  • Revenue Next Year
  • LGND $18.87
  • EBC $28.88
  • P/E Ratio
  • LGND N/A
  • EBC $72.02
  • Revenue Growth
  • LGND 53.40
  • EBC 3.05
  • 52 Week Low
  • LGND $81.74
  • EBC $13.51
  • 52 Week High
  • LGND $129.90
  • EBC $19.40
  • Technical
  • Relative Strength Index (RSI)
  • LGND 66.71
  • EBC 46.69
  • Support Level
  • LGND $182.87
  • EBC $16.62
  • Resistance Level
  • LGND $194.44
  • EBC $18.78
  • Average True Range (ATR)
  • LGND 5.79
  • EBC 0.71
  • MACD
  • LGND -0.38
  • EBC -0.16
  • Stochastic Oscillator
  • LGND 81.23
  • EBC 38.20

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About EBC Eastern Bankshares Inc.

Eastern Bankshares Inc is a commercial bank that caters its products and services to retail, commercial, and small business customers. Its diversified products and services include lending, deposit, wealth management, and insurance products. The company has one operating segment; Banking business which offers a range of banking lending, savings, and small business offerings, and its wealth management and trust operations.

Share on Social Networks: